A new study from VIB and KU Leuven has revealed that Parkinson's disease comprises five distinct molecular subtypes, each requiring tailored therapeutic approaches.
Drug diversion remains a persistent challenge for hospitals and health systems, putting both patient safety and workforce wellbeing at risk. The impact doesn’t stop there – diversion can also create ...
A new study led by researchers from VIB and KU Leuven shows that Parkinson's disease can be divided into distinct subtypes, ...